Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease | MicrobiomeTrials← Back to trialsNCT07877649
Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2032-10-31
Enrollment target: 2,000 participants Other microbiome trials you might be interested in
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029